Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a major public health challenge worldwide. Owing to the emergence of novel viral variants, the risks of reinfections and vaccine breakthrough infections has increased co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ju-Pi, Wu, Kang-Hsi, Chao, Wan-Ru, Lee, Yi-Ju, Yang, Shun-Fa, Chao, Yu-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331939/
https://www.ncbi.nlm.nih.gov/pubmed/35897770
http://dx.doi.org/10.3390/ijms23158196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331939/
https://www.ncbi.nlm.nih.gov/pubmed/35897770
http://dx.doi.org/10.3390/ijms23158196

Ejemplares similares